About this trial
The current study focuses in clinical validation of the efficacy of nutraceutical product in the management of mental focus and cognition. The benefits of these nutraceuticals extend beyond mere cognitive enhancement. Improved mental focus can lead to increased productivity and efficiency in both personal and professional settings. Individuals who struggle with attention deficits or cognitive fog may find that these supplements help them maintain a sharper and more consistent level of mental clarity. This can translate to better performance at work, as well as improved ability to manage daily tasks and responsibilities.
Eligibility criteria
Qualifiers
Male and female participants aged 18-50 years both inclusive
Suffering from self-reported mild to moderate stress on the PSS scale score less than or equal to 26
Scoring 18-26 on the Montreal Cognitive Assessment MoCA
No or minimal impairment in activities of daily living: scoring less than 9 on the Functional Activities Questionnaire FAQ
Disqualifiers
Inability to perform any of the assessments required for endpoint analysis
Shows signs of Dementia, such as caused by Alzheimer's Disease, acquired immunodeficiency syndrome AIDS, Creutzfeldt-Jakob disease, Lewy Bodies dementia LBD, Cerebrovascular dementia CVD, Progressive Supranuclear Palsy PSP, multiple cerebral infarctions, or normal pressure hydrocephalus NPH, cardiac disease or endocrine disease
Have any other neurodegenerative diseases
History of a seizure disorder
Trial design
Treatments tested in this trial
- De-Stress and Focus capsule- U001
- De-Stress and Focus capsule - I001
- Placebo capsules 001